NSD2 and prostate carcinoma: In addition, mouse xenograft models established with prostate cancer cells carrying the NSD2 S172A mutant alleles exhibit substantially reduced numbers of metastatic lesions in the limbs, underscoring the crucial role of AKT-mediated phosphorylation and subsequent stabilization of NSD2 in prostate cancer metastasis.